Evidence map›Paper›PMID 18773489›Full record

ReviewDevelopmental dynamics : an official publication of the American Association of Anatomists2009

Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease.

Siyun Liao, Janet Bodmer, Daniel Pietras, Mohamad Azhar, Tom Doetschman, Jo El J Schultz

Open access · greenAbstract readReview
In one paragraph

Review in Developmental dynamics : an official publication of the American Association of Anatomists, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. FGF2 is secreted in extracellular vesicles from lung cells.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Siyun LiaoDepartment of Pharmacology and Cell Biophysics, University of Cincinnati, Cincinnati, Ohio, USA.
Janet Bodmer
Daniel Pietras
Mohamad Azhar
Tom Doetschman
Jo El J Schultz
University of Cincinnati · USUniversity of Arizona · US

Funding

Signaling Mechanisms of FGF2-induced CardioprotectionR01HL075633 · NHLBI · UNIVERSITY OF CINCINNATI · PI SCHULTZ, JOEL J · 2004 to 2014
$3.5M
Roles of FGF2 and TGFbeta in cardiac hypertrophyR01HL070174 · NHLBI · UNIVERSITY OF CINCINNATI · PI DOETSCHMAN, THOMAS · 2002 to 2005
$1.5M
Signaling Mechanisms of FGF2-induced CardioprotectionR56HL075633 · NHLBI · UNIVERSITY OF CINCINNATI · PI SCHULTZ, JOEL J · 2009 to 2009
$393k
GROWTH FACTORS IN VASCULAR SMOOTH MUSCLER01HL058511 · NHLBI · UNIVERSITY OF CINCINNATI · PI DOETSCHMAN, THOMAS · 1997 to 2000
$223k
NHLBI NIH HHS HL070174NHLBI NIH HHS HL075633NHLBI NIH HHS R01 HL058511NHLBI NIH HHS R01 HL070174NHLBI NIH HHS R01 HL075633NHLBI NIH HHS R56 HL075633
6 · The paper itself

Abstract

Fibroblast growth factor 2 (FGF2) consists of multiple protein isoforms (low molecular weight, LMW, and high molecular weight, HMW) produced by alternative translation from the Fgf2 gene. These protein isoforms are localized to different cellular compartments, indicating unique biological activity. FGF2 isoforms in the heart have distinct roles in many pathological circumstances in the heart including cardiac hypertrophy, ischemia-reperfusion injury, and atherosclerosis. These studies suggest distinct biological activities of FGF2 LMW and HMW isoforms both in vitro and in vivo. Yet, due to the limitations that only the recombinant FGF2 LMW isoform is readily available and that the FGF2 antibody is nonspecific with regards to its isoforms, much remains to be determined regarding the role(s) of the FGF2 LMW and HMW isoforms in cellular behavior and in cardiovascular development and pathophysiology. This review summarizes the activities of LMW and HMW isoforms of FGF2 in cardiovascular development and disease.

Indexed as

Neovascularization, PathologicAnimalsAorta, ThoracicCardiovascular DiseasesCardiovascular SystemFibroblast Growth Factor 2Heart ValvesMiceMice, KnockoutProtein IsoformsFibroblast Growth Factor 2Protein Isoforms

Identifiers

PMID18773489
PMCPMC3115589
OpenAlexW2062837681

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.